Citigroup’s Korro Bio KRRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$68.1K Buy
5,169
+4,861
+1,578% +$60.4K ﹤0.01% 4873
2026
Q1
$3.49K Sell
308
-299
-49% -$3.29K ﹤0.01% 5337
2025
Q4
$4.86K Buy
607
+270
+80% +$6.31K ﹤0.01% 5253
2025
Q3
$16.1K Sell
337
-2,147
-86% -$47.6K ﹤0.01% 4880
2025
Q2
$31K Sell
2,484
-2,347
-49% -$33.8K ﹤0.01% 4969
2025
Q1
$84.1K Sell
4,831
-467
-9% -$13.8K ﹤0.01% 4690
2024
Q4
$202K Buy
5,298
+866
+20% +$44.5K ﹤0.01% 4407
2024
Q3
$148K Buy
4,432
+3,074
+226% +$129K ﹤0.01% 4557
2024
Q2
$46K Sell
1,358
-17,931
-93% -$991K ﹤0.01% 4630
2024
Q1
$1.74M Buy
19,289
+2,282
+13% +$125K ﹤0.01% 2552
2023
Q4
$815K Buy
+17,007
New +$560K ﹤0.01% 3011
2022
Q4
Sell
-8
Closed -$1K 5860
2022
Q3
$1K Sell
8
-20
-71% -$2.03K ﹤0.01% 5642
2022
Q2
$2K Sell
28
-24
-46% -$1.62K ﹤0.01% 5892
2022
Q1
$6K Sell
52
-132
-72% -$25.2K ﹤0.01% 5753
2021
Q4
$47K Buy
184
+66
+56% +$20.1K ﹤0.01% 5099
2021
Q3
$41K Sell
118
-141
-54% -$55.5K ﹤0.01% 4842
2021
Q2
$130K Sell
259
-1,295
-83% -$632K ﹤0.01% 4419
2021
Q1
$738K Buy
1,554
+1,430
+1,153% +$2.78M ﹤0.01% 3196
2020
Q4
$218K Buy
124
+100
+417% +$132K ﹤0.01% 4922
2020
Q3
$23K Sell
24
-53
-69% -$56.9K ﹤0.01% 6090
2020
Q2
$90K Buy
77
+42
+120% +$37.9K ﹤0.01% 5667
2020
Q1
$31K Buy
35
+12
+52% +$13K ﹤0.01% 6378
2019
Q4
$21K Buy
+23
New +$17.9K ﹤0.01% 6915

Other funds holding KRRO

Citigroup's KRRO Position: Q2 2026 in Review

Citigroup increased its Korro Bio (KRRO) stake by 1,578% in Q2 2026, buying an estimated $60.4K and bringing the position to 5,169 shares worth $68.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4873.

Citigroup first reported a position in KRRO in Q4 2019 and has held it in 23 quarters since. The position peaked at $1.74M in Q1 2024. 17 funds tracked by Wall St. Rank hold KRRO as of Q2 2026.

  • Citigroup held 5,169 shares of Korro Bio worth $68.1K as of Q2 2026.
  • Citigroup bought 4,861 Korro Bio shares in Q2 2026, an estimated $60.4K.
  • Korro Bio made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #4873 holding.
  • Citigroup first reported a position in Korro Bio in Q4 2019 and has held it in 23 quarters since.
  • Citigroup's Korro Bio position peaked at $1.74M in Q1 2024.
  • 17 funds tracked by Wall St. Rank held Korro Bio as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.